José Patrocinio Ribeiro Cruz Neto

Mr. José Patrocinio Ribeiro Cruz Neto


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2024 in Foods
Verified
Journal Article
Open access
PDF file
JNJosé Patrocinio Ribeiro Cruz Neto
José Patrocinio Ribeiro Cruz Neto
MFMicaelle Oliveira de Luna Freire
Micaelle Oliveira de Luna Freire
DLDeborah Emanuelle de Albuquerque Lemos
Deborah Emanuelle de Albuquerque Lemos
RARayanne Maira Felix Ribeiro Alves
Rayanne Maira Felix Ribeiro Alves
ECEmmily Ferreira de Farias Cardoso
Emmily Ferreira de Farias Cardoso
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
Atherosclerosis (AS) is a chronic inflammatory vascular disease. Dysregulated lipid metabolism, oxidative stress, and inflammation are the major mechanisms implicated in the development of AS. In addition, evidence suggests that gut dysbiosis plays an important role in atherogenesis, and modulation of the gut microbiota with probiotics and phenolic compounds has emerged as a promising strategy for preventing and treating AS. It has been shown that probiotics and phenolic compounds can improve atherosclerosis-related parameters by improving lipid profile, oxidative stress, and inflammation. In addition, these compounds may modulate the diversity and composition of the gut microbiota and improve atherosclerosis. The studies evaluated in the present review showed that probiotics and phenolic compounds, when consumed individually, improved atherosclerosis by modulating the gut microbiota in various ways, such as decreasing gut permeability, decreasing TMAO and LPS levels, altering alpha and beta diversity, and increasing fecal bile acid loss. However, no study was found that evaluated the combined use of probiotics and phenolic compounds to improve atherosclerosis. The available literature highlights the synergistic potential between phenolic compounds and probiotics to improve their health-promoting properties and functionalities. This review aims to summarize the available evidence on the individual effects of probiotics and phenolic compounds on AS, while providing insights into the potential benefits of nutraceutical approaches using probiotic strains, quercetin, and resveratrol as potential adjuvant therapies for AS treatment through modulation of the gut microbiota.

8 September 2022 in Foods
Verified
Journal Article
Open access
PDF file
PCPaulo César Trindade Costa
Paulo César Trindade Costa
JAJailane Aquino
Jailane Aquino
DLDiego Lacerda
Diego Lacerda
JNJosé Patrocinio Ribeiro Cruz Neto
José Patrocinio Ribeiro Cruz Neto
LSLudmilla Sales
Ludmilla Sales
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
Quercetin supplementation during pregnancy and lactation has been linked to a lower risk of maternal cardio-metabolic disorders such as gestational diabetes mellitus (GDM), dyslipidemia, preeclampsia, attenuation of malnutrition-related conditions, and gestational obesity in animal studies. Pre-clinical studies have shown that maternal supplementation with quercetin reduces cardio-metabolic diseases in dams and rodents’ offspring, emphasizing its role in modifying phenotypic plasticity. In this sense, it could be inferred that quercetin administration during pregnancy and lactation is a viable strategy for changing cardio-metabolic parameters throughout life. Epigenetic mechanisms affecting the AMP-activated protein kinase (AMPK), nuclear factor-kappa B (NF-κB), and phosphoinositide 3-kinase (PI3 K) pathways could be associated with these changes. To highlight these discoveries, this review outlines the understanding from animal studies investigations about quercetin supplementation and its capacity to prevent or decrease maternal and offspring cardio-metabolic illnesses and associated comorbidities.

20 November 2024 in Cosmetics
Verified
Journal Article
Open access
PDF file
EBEcem Bolat
Ecem Bolat
ZKZeynep Karagöz
Zeynep Karagöz
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
JNJosé Patrocinio Ribeiro Cruz Neto
José Patrocinio Ribeiro Cruz Neto
Anna Maria WitkowskaAnna Maria Witkowska
Anna Maria Witkowska
Sercan KaravSercan Karav
Sercan Karav
Skin is a crucial organ for preserving the body’s equilibrium. Like other parts of the body, skin also ages due to extrinsic and intrinsic factors, leading to several signs such as wrinkles, spots, and a decline in elasticity, causing a range of issues similar to those seen elsewhere in the body. Some of these factors include ultraviolet (UV) radiation, hormonal disorders, genetic factors, loss of moisture, metabolic disorders, exposure to chemicals, and smoking. Colostrum, which is the initial foremilk, has shown positive effects on the consequences of these factors. Its content is richer than mature milk and contains several beneficial components. For instance, it includes hyaluronic acid, a molecule that binds water and keeps the skin hydrated; lactoferrin, with high antimicrobial properties; immunoglobulins, which are responsible for immunity; growth factors, which increase the amount of collagen, the main protein type of the skin; and, finally, the telomerase enzyme, which maintains the telomere’s length and, thus, decelerates the aging process. It has recently become apparent that using skin products with natural ingredients is essential. Considering its nature, contents, and effects, colostrum stands out as an excellent material for the cosmetic industry, especially for the aging sector. Therefore, the aim of this review article is to demonstrate the potential application of natural colostrum in skin health and its usage in natural cosmetic products in the cosmetic sector.

26 March 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
LSLucas Alves Carneiro dos Santos
Lucas Alves Carneiro dos Santos
RCRodrigo Carvalho
Rodrigo Carvalho
JNJosé Patrocinio Ribeiro Cruz Neto
José Patrocinio Ribeiro Cruz Neto
DLDeborah Emanuelle de Albuquerque Lemos
Deborah Emanuelle de Albuquerque Lemos
KOKataryne de Oliveira
Kataryne de Oliveira
JAJosé Luiz de Brito Alves
José Luiz de Brito Alves
Multi-strain Limosilactobacillus (L.) fermentum is a potential probiotic with reported immunomodulatory properties. This study aimed to evaluate the composition, richness, and diversity of the gut microbiota in male and female rats after treatment with a multi-strain of L. fermentum at different doses. Thirty rats (fifteen male and fifteen female) were allocated into a control group (CTL), a group receiving L. fermentum at a dose of 108 CFU (Lf-108), and a group receiving L. fermentum at a dose of 1010 CFU (Lf-1010) for 13 weeks. Gut microbiota and serum cytokine levels were evaluated after L. fermentum treatment. Male CTL rats had a lower relative abundance of Bifidobacteriaceae and Prevotella and a lower alpha diversity than their female CTL counterparts (p < 0.05). In addition, male CTL rats had a higher Firmicutes/Bacteroidetes (F/B) ratio than female CTL rats (p < 0.05). In female rats, the administration of L. fermentum at 108 CFU decreased the relative abundance of Bifidobacteriaceae and Anaerobiospirillum and increased Lactobacillus (p < 0.05). In male rats, the administration of L. fermentum at 1010 CFU decreased the F/B ratio and increased Lachnospiraceae and the diversity of the gut microbiota (p < 0.05). The relative abundance of Lachnospiraceae and the alpha-diversity of gut microbiota were negatively correlated with serum levels of IL1β (r = −0.44) and TNFα (r = −0.39), respectively. This study identified important changes in gut microbiota between male and female rats and showed that a lower dose of L. fermentum may have more beneficial effects on gut microbiota in females, while a higher dose may result in more beneficial effects on gut microbiota in male rats.